Clinicians prescribing BPC-157 off-label do so based on preclinical data, mechanistic plausibility, and patient-reported outcomes, not a regulatory evidence package
The most effective protocols appear to combine anti-inflammatory peptides like BPC-157 with tissue repair peptides such as TB-500
Hydrolyzed collagen powders with peptides under 3,000 daltons show superior absorption compared to larger molecular weight forms
Foundayo (orforglipron), developed by Eli Lilly, is a new, once-daily oral GLP-1 weight-loss pill approved in the UAE (second globally after the US) and expected to be available from May 2026
This combination is designed to support weight loss efforts, boost metabolism, and promote liver health [2]
In addition, there is a likely analogy (see for review i.e., (Seiwerth et al., 2018)) with the attenuated fibrosis and scar formation in other tissues (i.e., the skin, muscle, tendon, and ligament) (Mikus et al., 2001